PUBLISHER: The Insight Partners | PRODUCT CODE: 2165927
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165927
The Middle East and Africa Automated Peritoneal Dialysis Market is projected to expand from US$ 76.9 Million in 2025 to US$ 103.6 Million by 2034. The market is expected to register a CAGR of 3.4% during the forecast period from 2026 to 2034.
Executive Summary and Middle East and Africa Automated Peritoneal Dialysis Market Analysis
The Middle East & Africa (MEA) automated peritoneal dialysis market is experiencing gradual growth, supported by the increasing prevalence of chronic kidney disease (CKD), broader access to kidney replacement therapies, and ongoing improvements in regional healthcare infrastructure. According to the 2023 International Society of Nephrology (ISN) Global Kidney Health Atlas, the prevalence of treated kidney failure, including dialysis and transplantation, ranged from 152 to 869 patients per million population across the region. This wide range reflects a substantial and expanding population requiring renal replacement treatment.
The prevalence of chronic dialysis, encompassing both hemodialysis and peritoneal dialysis, was estimated at approximately 350.5 patients per million population in the region, with PD representing a portion of this treatment base. The MEA region also faces a considerable CKD burden, with median prevalence estimated at 8.2%, ranging from 4.9% in Yemen to 12.2% in Lebanon. These trends indicate a growing requirement for accessible and flexible renal replacement solutions.
Technological progress is helping improve the practicality of home-based dialysis in markets where peritoneal dialysis services are established. Automated cyclers equipped with remote monitoring functions, advanced safety mechanisms, and improved treatment controls are making APD increasingly feasible for suitable patients. In addition, several governments across the MEA region are increasing investments in kidney care infrastructure, dialysis services, and renal disease registries. Some countries also provide substantial or complete financial coverage for dialysis treatments, helping reduce access barriers and supporting greater choice among treatment modalities.
The increasing prevalence of diabetes and hypertension, both major contributors to kidney disease, further supports demand for dialysis services. Together, these healthcare, demographic, technological, and disease-related factors are contributing to the gradual expansion of the Automated Peritoneal Dialysis Market across the Middle East & Africa.
Strategic Insights
Middle East and Africa Automated Peritoneal Dialysis Market Segmentation Analysis
By Product Type, the Middle East and Africa Automated Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment dominated the market in 2025.
By End User, the Middle East and Africa Automated Peritoneal Dialysis Market is categorized into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment held the dominant position in 2025.
Market Report Scope
Middle East and Africa Automated Peritoneal Dialysis Market Outlook
Quality-of-life considerations are becoming increasingly important in dialysis modality selection as nephrology practices move beyond traditional measures such as treatment adequacy and survival outcomes. Automated peritoneal dialysis, particularly when performed overnight, allows patients to complete their treatment while sleeping and preserve greater independence during daytime hours. This flexibility can enable patients to continue working, participating in social activities, and maintaining leisure routines, contributing to the growing preference for APD in healthcare systems where home dialysis is well established.
The quality-of-life benefits associated with APD also extend to caregivers and family members. Because automated treatment reduces the need for manual exchanges during waking hours, caregivers may spend less time directly assisting with dialysis procedures. This can reduce the day-to-day responsibilities associated with home dialysis and allow family members to balance caregiving with employment and other personal obligations.
Furthermore, the automated nature of APD can reduce patient anxiety associated with performing repeated manual exchanges and may lower the likelihood of errors related to manual technique. Greater automation can therefore strengthen patient confidence and make self-managed treatment more manageable.
These quality-of-life advantages are receiving greater attention in clinical recommendations and shared decision-making discussions. As healthcare providers increasingly consider patient preferences, independence, caregiver requirements, and lifestyle factors when selecting dialysis modalities, APD can offer an attractive option for appropriately selected patients.
Middle East and Africa Automated Peritoneal Dialysis Market Country Insights
By country, the Middle East and Africa Automated Peritoneal Dialysis Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. The Rest of Middle East and Africa segment accounted for the largest market share in 2025.
Countries such as Israel, Iraq, Oman, Iran, Turkey, Kuwait, and Kenya represent important contributors to the automated peritoneal dialysis market within the Rest of Middle East & Africa. Market development across these countries is being supported by increasing CKD prevalence, improvements in healthcare systems, greater awareness of renal replacement options, and the gradual diversification of dialysis treatment modalities.
According to the 2023 ISN Global Kidney Health Atlas, the prevalence of treated kidney failure across Middle Eastern countries ranged from approximately 152 patients per million population in the UAE to 869 patients per million in Kuwait. This variation reflects both differences in disease burden and healthcare capacity, while also demonstrating a substantial population requiring dialysis services.
Iran faces a significant CKD burden, influenced in part by high rates of diabetes and hypertension. The resulting demand for renal replacement therapy is creating opportunities for broader adoption of PD and APD. Turkey has also continued to strengthen its renal care infrastructure and patient education initiatives, supporting awareness and consideration of alternative dialysis modalities.
Kuwait's high treated kidney failure prevalence of approximately 869 patients per million indicates substantial clinical demand alongside healthcare capacity capable of supporting multiple renal replacement approaches. Israel's advanced healthcare system provides extensive CKD monitoring and dialysis coverage, creating favorable conditions for APD implementation among suitable patients.
Meanwhile, Oman and Iraq are continuing to develop renal disease registries and expand access to dialysis services. In Eastern Africa, Kenya is strengthening CKD screening, early detection, and referral systems, which can contribute to future growth in renal replacement therapy demand. Across these diverse markets, increased healthcare investment, professional training, improved treatment infrastructure, and growing availability of automated dialysis technologies are collectively supporting expansion of the APD market.
Middle East and Africa Automated Peritoneal Dialysis Market Company Profiles
Major companies operating in the Middle East and Africa Automated Peritoneal Dialysis Market include Terumo Corp, Medtronic Plc, Asahi Kasei Corp, Baxter International Inc, Fresenius Medical Care AG & Co KGaA, B. Braun SE, Angiplast, Becton Dickinson and Co, Utah Medical Products Inc, and Poly Medicure Ltd.
These companies are implementing a range of strategies, including geographic expansion, product innovation, strategic development, and mergers and acquisitions. Such initiatives are focused on strengthening product portfolios, introducing advanced dialysis technologies, addressing evolving patient and healthcare-provider needs, and expanding market share across the region.